150 related articles for article (PubMed ID: 335881)
21. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
Tatoń J; Czech A; Podgórski G
Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
[No Abstract] [Full Text] [Related]
22. [4 varieties of islet cell antibodies in 74 insulin-dependent diabetics and their families as a function of the HLA genotype].
Vexiau P; Helmy-Khalil S; Mamoun F; Homberg JC; Cathelineau G; Deschamps I; Busson M; Hors J
Presse Med; 1986 Feb; 15(8):383-6. PubMed ID: 2938157
[TBL] [Abstract][Full Text] [Related]
23. Autoimmunity and histocompatibility antigens in diabetes mellitus of childhood [proceedings].
Illeni MT; Pellegris G; Del Guercio MJ; Tarantino A; Busetto F; Di Pietro C; Clerici E; Chiumello G
Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 795691
[No Abstract] [Full Text] [Related]
24. HLA and pancreatic islet cell antibodies in diabetes [proceedings].
Morris PJ; Vaughan H; McCallum CJ; Gray RS; Irvine WJ; Campbell CJ; Duncan LJ; Farquhar JW
Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 795692
[No Abstract] [Full Text] [Related]
25. [Role of autoimmune processes in the pathogenesis of diabetes mellitus].
Sil'nitskiĭ PA; Shabanova LF
Klin Med (Mosk); 1980 Oct; 58(10):22-6. PubMed ID: 7003240
[No Abstract] [Full Text] [Related]
26. HLA, islet cell antibodies, and types of diabetes mellitus.
Nerup J; Platz P; Ryder LP; Thomsen M; Svejgaard A
Diabetes; 1978; 27 Suppl 1():247-50. PubMed ID: 344116
[TBL] [Abstract][Full Text] [Related]
27. Genetic and humoral markers in IDDM patients and their families.
Ruiz M; Puchulu FE; Florin Christensen A
Adv Exp Med Biol; 1988; 246():241-7. PubMed ID: 3074656
[No Abstract] [Full Text] [Related]
28. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
Baekkeskov S
Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
[TBL] [Abstract][Full Text] [Related]
29. [Should screening for type 1 diabetes be encouraged in brothers and sisters of diabetic children?].
Lévy-Marchal C
Diabete Metab; 1992; 18(1):65-8. PubMed ID: 1563541
[No Abstract] [Full Text] [Related]
30. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and etiological markers in insulin-dependent diabetes associated with an organ-specific autoimmune disease.
Prince MA; Vialettes B; Zevaco-Mattei C; Vague P
Acta Diabetol Lat; 1983; 20(3):221-9. PubMed ID: 6314721
[TBL] [Abstract][Full Text] [Related]
32. Genetics of type 1A diabetes.
Sepe V; Loviselli A; Bottazzo GF
N Engl J Med; 2009 Jul; 361(2):211. PubMed ID: 19587353
[No Abstract] [Full Text] [Related]
33. Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus.
Serjeantson S; Theophilus J; Zimmet P; Court J; Crossley JR; Elliott RB
Diabetes; 1981 Jan; 30(1):26-9. PubMed ID: 7014302
[TBL] [Abstract][Full Text] [Related]
34. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
35. Islet-cell-surface antibodies in juvenile diabetes mellitus.
Lernmark A; Freedman ZR; Hofmann C; Rubenstein AH; Steiner DF; Jackson RL; Winter RJ; Traisman HS
N Engl J Med; 1978 Aug; 299(8):375-80. PubMed ID: 353557
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a primary autoimmune type of diabetes mellitus.
Bottazzo GF; Cudworth AG; Moul DJ; Doniach D; Festenstein H
Br Med J; 1978 Nov; 2(6147):1253-5. PubMed ID: 361163
[TBL] [Abstract][Full Text] [Related]
37. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.
Madsbad S
Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267
[No Abstract] [Full Text] [Related]
38. HLA-B8 in caucasian patients with systemic lupus erythematosus.
Scherak O; Kolarz G; Mayr WR
Scand J Rheumatol; 1978; 7(1):3-6. PubMed ID: 307811
[TBL] [Abstract][Full Text] [Related]
39. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.
Baekkeskov S; Landin M; Kristensen JK; Srikanta S; Bruining GJ; Mandrup-Poulsen T; de Beaufort C; Soeldner JS; Eisenbarth G; Lindgren F
J Clin Invest; 1987 Mar; 79(3):926-34. PubMed ID: 3546382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
